279 related articles for article (PubMed ID: 31627816)
1. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson's disease - A review.
Hassan Q; Li S; Ferrag C; Kerman K
Anal Chim Acta; 2019 Dec; 1089():32-39. PubMed ID: 31627816
[TBL] [Abstract][Full Text] [Related]
2. A novel, label-free liquid crystal biosensor for Parkinson's disease related alpha-synuclein.
Yang X; Li H; Zhao X; Liao W; Zhang CX; Yang Z
Chem Commun (Camb); 2020 May; 56(40):5441-5444. PubMed ID: 32292959
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein in Parkinson's disease and advances in detection.
Chen R; Gu X; Wang X
Clin Chim Acta; 2022 Apr; 529():76-86. PubMed ID: 35176268
[TBL] [Abstract][Full Text] [Related]
4. Efficient Entrapment of Alpha-Synuclein Biotinylated Antibody in KCC-1-NH-CS
Navay Baghban H; Hasanzadeh M; Liu Y; Seidi F
Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291047
[TBL] [Abstract][Full Text] [Related]
5. Electrochemiluminescent aptamer-sensor for alpha synuclein oligomer based on a metal-organic framework.
Wu Q; Tan R; Mi X; Tu Y
Analyst; 2020 Mar; 145(6):2159-2167. PubMed ID: 32129373
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
Atik A; Stewart T; Zhang J
Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
[TBL] [Abstract][Full Text] [Related]
7. New Insights into the Biosensing of Parkinson's Disease Biomarkers: A Concise Review.
Hosseini ES; Mohammadi S; Khodarahmi R; Fouani MH; Tavallaei O; Jaberi KR; Shabaninejad Z; Janfaza S; Yazdian-Robati R; Sajadimajd S
Curr Med Chem; 2022; 29(22):3945-3972. PubMed ID: 34961452
[TBL] [Abstract][Full Text] [Related]
8. An Electrochemical Immunosensor Based on a Self-Assembled Monolayer Modified Electrode for Label-Free Detection of α-Synuclein.
Ge CY; Rahman MM; Zhang W; Lopa NS; Jin L; Yoon S; Jang H; Xu GR; Kim W
Sensors (Basel); 2020 Jan; 20(3):. PubMed ID: 31979160
[TBL] [Abstract][Full Text] [Related]
9. A review of the current research on in vivo and in vitro detection for alpha-synuclein: a biomarker of Parkinson's disease.
Wang R; Pang SC; Li JY; Li CL; Liu JM; Wang YM; Chen ML; Li YB
Anal Bioanal Chem; 2023 Apr; 415(9):1589-1605. PubMed ID: 36688984
[TBL] [Abstract][Full Text] [Related]
10. Electrochemical Aptamer Scaffold Biosensors for Detection of Botulism and Ricin Proteins.
Daniel J; Fetter L; Jett S; Rowland TJ; Bonham AJ
Methods Mol Biol; 2017; 1600():9-23. PubMed ID: 28478553
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.
Herrmann Y; Bujnicki T; Zafiu C; Kulawik A; Kühbach K; Peters L; Fabig J; Willbold J; Bannach O; Willbold D
Clin Chim Acta; 2017 Mar; 466():152-159. PubMed ID: 28088342
[TBL] [Abstract][Full Text] [Related]
12. A novel electrochemical aptasensor based on nontarget-induced high accumulation of methylene blue on the surface of electrode for sensing of α-synuclein oligomer.
Taghdisi SM; Danesh NM; Nameghi MA; Ramezani M; Alibolandi M; Hassanzadeh-Khayat M; Emrani AS; Abnous K
Biosens Bioelectron; 2019 Jan; 123():14-18. PubMed ID: 30278340
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
[TBL] [Abstract][Full Text] [Related]
14. Lab-made disposable screen-printed electrochemical sensors and immunosensors modified with Pd nanoparticles for Parkinson's disease diagnostics.
Orzari LO; Silva LRGE; de Freitas RC; Brazaca LC; Janegitz BC
Mikrochim Acta; 2024 Jan; 191(1):76. PubMed ID: 38172448
[TBL] [Abstract][Full Text] [Related]
15. Biosensors in Parkinson's disease.
Mobed A; Razavi S; Ahmadalipour A; Shakouri SK; Koohkan G
Clin Chim Acta; 2021 Jul; 518():51-58. PubMed ID: 33753044
[TBL] [Abstract][Full Text] [Related]
16. Current Progress in Aptasensor for Ultra-Low Level Monitoring of Parkinson's Disease Biomarkers.
Margiana R; Hammid AT; Ahmad I; Alsaikhan F; Turki Jalil A; Tursunbaev F; Umar F; Romero Parra RM; Fakri Mustafa Y
Crit Rev Anal Chem; 2024; 54(3):617-632. PubMed ID: 35754381
[TBL] [Abstract][Full Text] [Related]
17. Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.
Shahaduzzaman M; Nash K; Hudson C; Sharif M; Grimmig B; Lin X; Bai G; Liu H; Ugen KE; Cao C; Bickford PC
PLoS One; 2015; 10(2):e0116841. PubMed ID: 25658425
[TBL] [Abstract][Full Text] [Related]
18. An innovative method for the detection of alpha synuclein, a potential biomarker of Parkinson's disease: quartz tuning fork-based mass sensitive immunosensor design.
Sonuç Karaboğa MN; Ünal MA; Arı F; Sezgintürk MK; Özkan SA
Phys Chem Chem Phys; 2024 Feb; 26(6):5106-5114. PubMed ID: 38259152
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system.
Sonuç Karaboğa MN; Sezgintürk MK
Analyst; 2019 Jan; 144(2):611-621. PubMed ID: 30457584
[TBL] [Abstract][Full Text] [Related]
20. Gold-nanourchin seeded single-walled carbon nanotube on voltammetry sensor for diagnosing neurogenerative Parkinson's disease.
Zhang R; Wang S; Huang X; Yang Y; Fan H; Yang F; Li J; Dong X; Feng S; Anbu P; Gopinath SCB; Xin T
Anal Chim Acta; 2020 Jan; 1094():142-150. PubMed ID: 31761041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
